Covalon CFO Danny Brannagan To Step Down In January 2022

12:08pm, Friday, 24'th Dec 2021 Business Insider Markets
(RTTNews) - Covalon Technologies Ltd. (CVALF) said that its Chief Financial Officer Danny Brannagan will be stepping down in January 2022 to pursue other endeavours. The company plans to appoint an interim Chief Financial Officer while it undertakes a search for a new Chief Financial Officer. Covalon Technologies is a researcher, developer,
UpHealth (NYSE:UPH) and Covalon Technologies (OTCMKTS:CVALF) are both small-cap medical companies, but which is the better business? We will compare the two businesses based on the strength of their risk, analyst recommendations, dividends, institutional ownership, profitability, valuation and earnings. Analyst Ratings This is a breakdown of recent recommendations and price targets for UpHealth and Covalon []
Covalon Technologies Ltd. (OTCMKTS:CVALF) was the target of a large growth in short interest in the month of November. As of November 30th, there was short interest totalling 9,000 shares, a growth of 462.5% from the November 15th total of 1,600 shares. Based on an average daily volume of 5,700 shares, the days-to-cover ratio is […]
Covalon Technologies (CVALF) CEO Brian Pedlar on Q4 2021 Results - Earnings Call Transcript

Covalon Technologies reports Q4 results

12:15pm, Monday, 13'th Dec 2021 Seeking Alpha

Covalon Technologies (COV) Scheduled to Post Earnings on Monday

01:40pm, Friday, 10'th Dec 2021 Transcript Daily
Covalon Technologies (CVE:COV) is scheduled to be issuing its quarterly earnings data before the market opens on Monday, December 13th. Shares of CVE COV opened at C$2.55 on Friday. The company has a current ratio of 0.71, a quick ratio of 0.42 and a debt-to-equity ratio of 217.37. Covalon Technologies has a 12 month low […]
MISSISSAUGA, ON, Dec. 8, 2021 /PRNewswire/ - Covalon Technologies Ltd. (the "Company" or "Covalon") (TSXV: COV) (OTCQX: CVALF), an advanced medical technologies company, will release its Q4 and year
Covalon Technologies (OTCMKTS:CVALF) and Sema4 (NASDAQ:SMFR) are both small-cap medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their earnings, risk, profitability, dividends, valuation, analyst recommendations and institutional ownership. Institutional and Insider Ownership 74.1% of Sema4 shares are owned by institutional investors. Strong institutional ownership []
MISSISSAUGA, ON / ACCESSWIRE / December 3, 2021 / Covalon Technologies Ltd. (the "Company" or "Covalon") (TSXV:COV)(OTCQX:CVALF), an advanced medical technologies company, today announced that it will

Covalon Announces Retirement of Board Member

08:00am, Friday, 24'th Sep 2021
MISSISSAUGA, ON, Sept. 24, 2021 /PRNewswire/ - Covalon Technologies Ltd.
Covalon Technologies (CVALF) CEO, Brian Pedlar on Q3 2021 Results - Earnings Call Transcript
MISSISSAUGA, ON, Aug. 26, 2021 /PRNewswire/ - Covalon Technologies Ltd. (the "Company" or "Covalon") (TSXV: COV) (OTCQX: CVALF), an advanced medical technologies company, will release its Q3 Fiscal 20
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE